Skip to main content
. 2017 Jul 26;8(39):65917–65931. doi: 10.18632/oncotarget.19579

Figure 2. Enzyme-Linked Immunosorbent Assay (ELISA) assessment of MPA1 biding to PRAME-Fc fusion protein.

Figure 2

MPA1 was serially diluted and added to wells containing immobilized PRAME-Fc fusion protein. An AP-conjugated secondary antibody allowed detection and absorbance corresponds to binding. Data is expressed as mean of duplicate results.